These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease. Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease. Bell PT; Gilat M; O'Callaghan C; Copland DA; Frank MJ; Lewis SJ; Shine JM Hum Brain Mapp; 2015 Apr; 36(4):1278-91. PubMed ID: 25425542 [TBL] [Abstract][Full Text] [Related]
6. Freezing of gait in Parkinson's disease is associated with functional decoupling between the cognitive control network and the basal ganglia. Shine JM; Matar E; Ward PB; Frank MJ; Moustafa AA; Pearson M; Naismith SL; Lewis SJ Brain; 2013 Dec; 136(Pt 12):3671-81. PubMed ID: 24142148 [TBL] [Abstract][Full Text] [Related]
12. Atomoxetine restores the response inhibition network in Parkinson's disease. Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257 [TBL] [Abstract][Full Text] [Related]
13. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication. Evens R; Hoefler M; Biber K; Lueken U Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease. Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278 [TBL] [Abstract][Full Text] [Related]
16. The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide? Aracil-Bolaños I; Sampedro F; Pujol J; Soriano-Mas C; Gónzalez-de-Echávarri JM; Kulisevsky J; Pagonabarraga J Hum Brain Mapp; 2021 Dec; 42(17):5736-5746. PubMed ID: 34510640 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of memory and affective processing in Parkinson depression. Blonder LX; Slevin JT; Kryscio RJ; Martin CA; Andersen AH; Smith CD; Schmitt FA Psychiatry Res; 2013 Nov; 210(1):146-9. PubMed ID: 23838419 [TBL] [Abstract][Full Text] [Related]